118 related articles for article (PubMed ID: 35472012)
1. TRAF3 alterations are frequent in del-3'IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features.
Pérez-Carretero C; Hernández-Sánchez M; González T; Quijada-Álamo M; Martín-Izquierdo M; Santos-Mínguez S; Miguel-García C; Vidal MJ; García-De-Coca A; Galende J; Pardal E; Aguilar C; Vargas-Pabón M; Dávila J; Gascón-Y-Marín I; Hernández-Rivas JÁ; Benito R; Hernández-Rivas JM; Rodríguez-Vicente AE
Am J Hematol; 2022 Jul; 97(7):903-914. PubMed ID: 35472012
[TBL] [Abstract][Full Text] [Related]
2. Chronic lymphocytic leukemia patients with IGH translocations are characterized by a distinct genetic landscape with prognostic implications.
Pérez-Carretero C; Hernández-Sánchez M; González T; Quijada-Álamo M; Martín-Izquierdo M; Hernández-Sánchez JM; Vidal MJ; de Coca AG; Aguilar C; Vargas-Pabón M; Alonso S; Sierra M; Rubio-Martínez A; Dávila J; Díaz-Valdés JR; Queizán JA; Hernández-Rivas JÁ; Benito R; Rodríguez-Vicente AE; Hernández-Rivas JM
Int J Cancer; 2020 Nov; 147(10):2780-2792. PubMed ID: 32720348
[TBL] [Abstract][Full Text] [Related]
3. Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia.
Quijada-Álamo M; Pérez-Carretero C; Hernández-Sánchez M; Rodríguez-Vicente AE; Herrero AB; Hernández-Sánchez JM; Martín-Izquierdo M; Santos-Mínguez S; Del Rey M; González T; Rubio-Martínez A; García de Coca A; Dávila-Valls J; Hernández-Rivas JÁ; Parker H; Strefford JC; Benito R; Ordóñez JL; Hernández-Rivas JM
Clin Transl Med; 2021 Feb; 11(2):e304. PubMed ID: 33634999
[TBL] [Abstract][Full Text] [Related]
4. Physiological role of the 3'IgH CBEs super-anchor in antibody class switching.
Zhang X; Yoon HS; Chapdelaine-Williams AM; Kyritsis N; Alt FW
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33441485
[TBL] [Abstract][Full Text] [Related]
5. A Low Frequency of Losses in 11q Chromosome Is Associated with Better Outcome and Lower Rate of Genomic Mutations in Patients with Chronic Lymphocytic Leukemia.
Hernández JÁ; Hernández-Sánchez M; Rodríguez-Vicente AE; Grossmann V; Collado R; Heras C; Puiggros A; Martín AÁ; Puig N; Benito R; Robledo C; Delgado J; González T; Queizán JA; Galende J; de la Fuente I; Martín-Núñez G; Alonso JM; Abrisqueta P; Luño E; Marugán I; González-Gascón I; Bosch F; Kohlmann A; González M; Espinet B; Hernández-Rivas JM;
PLoS One; 2015; 10(11):e0143073. PubMed ID: 26630574
[TBL] [Abstract][Full Text] [Related]
6. Biological and clinical characterization of recurrent 14q deletions in CLL and other mature B-cell neoplasms.
Reindl L; Bacher U; Dicker F; Alpermann T; Kern W; Schnittger S; Haferlach T; Haferlach C
Br J Haematol; 2010 Oct; 151(1):25-36. PubMed ID: 20649559
[TBL] [Abstract][Full Text] [Related]
7. Contribution of the IGCR1 regulatory element and the 3'
Liang Z; Zhao L; Ye AY; Lin SG; Zhang Y; Guo C; Dai HQ; Ba Z; Alt FW
Proc Natl Acad Sci U S A; 2023 Jun; 120(26):e2306564120. PubMed ID: 37339228
[TBL] [Abstract][Full Text] [Related]
8. IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics.
Nadeu F; Royo R; Clot G; Duran-Ferrer M; Navarro A; Martín S; Lu J; Zenz T; Baumann T; Jares P; Puente XS; Martín-Subero JI; Delgado J; Campo E
Blood; 2021 May; 137(21):2935-2946. PubMed ID: 33211804
[TBL] [Abstract][Full Text] [Related]
9. Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations.
Raponi S; Ilari C; Della Starza I; Cappelli LV; Cafforio L; Piciocchi A; Arena V; Mariglia P; Mauro FR; Gentile M; Cutrona G; Moia R; Favini C; Morabito F; Rossi D; Gaidano G; Guarini A; Del Giudice I; Foà R
Br J Haematol; 2020 Jun; 189(5):853-859. PubMed ID: 32064595
[TBL] [Abstract][Full Text] [Related]
10. Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: different genetic mechanisms but equivalent poorer clinical outcome.
Puiggros A; Venturas M; Salido M; Blanco G; Fernandez-Rodriguez C; Collado R; Valiente A; Ruiz-Xivillé N; Carrió A; Ortuño FJ; Luño E; Calasanz MJ; Ardanaz MT; Piñán MÁ; Talavera E; González MT; Ortega M; Marugán I; Ferrer A; Gimeno E; Bellosillo B; Delgado J; Hernández JÁ; Hernández-Rivas JM; Espinet B; ;
Genes Chromosomes Cancer; 2014 Sep; 53(9):788-97. PubMed ID: 24915757
[TBL] [Abstract][Full Text] [Related]
11. Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy.
Byrd JC; Gribben JG; Peterson BL; Grever MR; Lozanski G; Lucas DM; Lampson B; Larson RA; Caligiuri MA; Heerema NA
J Clin Oncol; 2006 Jan; 24(3):437-43. PubMed ID: 16344317
[TBL] [Abstract][Full Text] [Related]
12. Specific chromosomal IG translocations have different prognoses in chronic lymphocytic leukemia.
Nguyen-Khac F; Chapiro E; Lesty C; Grelier A; Luquet I; Radford-Weiss I; Lefebvre C; Fert-Ferrer S; Callet-Bauchu E; Lippert E; Raggueneau V; Michaux L; Barin C; Collonge-Rame MA; Mugneret F; Eclache V; Taviaux S; Dastugue N; Richebourg S; Struski S; Talmant P; Baranger L; Gachard N; Gervais C; Quilichini B; Settegrana C; Maloum K; Davi F; Merle-Béral H
Am J Blood Res; 2011; 1(1):13-21. PubMed ID: 22432063
[TBL] [Abstract][Full Text] [Related]
13. Biallelic inactivation of TRAF3 in a subset of B-cell lymphomas with interstitial del(14)(q24.1q32.33).
Nagel I; Bug S; Tönnies H; Ammerpohl O; Richter J; Vater I; Callet-Bauchu E; Calasanz MJ; Martinez-Climent JA; Bastard C; Salido M; Schroers E; Martin-Subero JI; Gesk S; Harder L; Majid A; Dyer MJ; Siebert R
Leukemia; 2009 Nov; 23(11):2153-5. PubMed ID: 19693093
[No Abstract] [Full Text] [Related]
14. Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study.
Bomben R; Dal Bo M; Capello D; Benedetti D; Marconi D; Zucchetto A; Forconi F; Maffei R; Ghia EM; Laurenti L; Bulian P; Del Principe MI; Palermo G; Thorsélius M; Degan M; Campanini R; Guarini A; Del Poeta G; Rosenquist R; Efremov DG; Marasca R; Foà R; Gaidano G; Gattei V
Blood; 2007 Apr; 109(7):2989-98. PubMed ID: 17148579
[TBL] [Abstract][Full Text] [Related]
15. 14q deletions are associated with trisomy 12, NOTCH1 mutations and unmutated IGHV genes in chronic lymphocytic leukemia and small lymphocytic lymphoma.
Cosson A; Chapiro E; Belhouachi N; Cung HA; Keren B; Damm F; Algrin C; Lefebvre C; Fert-Ferrer S; Luquet I; Gachard N; Mugneret F; Terre C; Collonge-Rame MA; Michaux L; Rafdord-Weiss I; Talmant P; Veronese L; Nadal N; Struski S; Barin C; Helias C; Lafage M; Lippert E; Auger N; Eclache V; Roos-Weil D; Leblond V; Settegrana C; Maloum K; Davi F; Merle-Beral H; Lesty C; Nguyen-Khac F;
Genes Chromosomes Cancer; 2014 Aug; 53(8):657-66. PubMed ID: 24729385
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of IgA- and/or IgG-switched chronic lymphocytic leukemia B cells.
Matolcsy A; Casali P; Nádor RG; Liu YF; Knowles DM
Blood; 1997 Mar; 89(5):1732-9. PubMed ID: 9057657
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation.
Fabbri G; Rasi S; Rossi D; Trifonov V; Khiabanian H; Ma J; Grunn A; Fangazio M; Capello D; Monti S; Cresta S; Gargiulo E; Forconi F; Guarini A; Arcaini L; Paulli M; Laurenti L; Larocca LM; Marasca R; Gattei V; Oscier D; Bertoni F; Mullighan CG; Foá R; Pasqualucci L; Rabadan R; Dalla-Favera R; Gaidano G
J Exp Med; 2011 Jul; 208(7):1389-401. PubMed ID: 21670202
[TBL] [Abstract][Full Text] [Related]
18. Biallelic ATM inactivation significantly reduces survival in patients treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 trial.
Skowronska A; Parker A; Ahmed G; Oldreive C; Davis Z; Richards S; Dyer M; Matutes E; Gonzalez D; Taylor AM; Moss P; Thomas P; Oscier D; Stankovic T
J Clin Oncol; 2012 Dec; 30(36):4524-32. PubMed ID: 23091097
[TBL] [Abstract][Full Text] [Related]
19. IGH Translocations in Chinese Patients With Chronic Lymphocytic Leukemia: Clinicopathologic Characteristics and Genetic Profile.
Li Q; Xing S; Zhang H; Mao X; Xiao M; Wang Y
Front Oncol; 2022; 12():858523. PubMed ID: 35720006
[TBL] [Abstract][Full Text] [Related]
20. Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness.
Messina M; Del Giudice I; Khiabanian H; Rossi D; Chiaretti S; Rasi S; Spina V; Holmes AB; Marinelli M; Fabbri G; Piciocchi A; Mauro FR; Guarini A; Gaidano G; Dalla-Favera R; Pasqualucci L; Rabadan R; Foà R
Blood; 2014 Apr; 123(15):2378-88. PubMed ID: 24550227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
